Search Results - "Peinert, S"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen by Peinert, S, Prince, H M, Guru, P M, Kershaw, M H, Smyth, M J, Trapani, J A, Gambell, P, Harrison, S, Scott, A M, Smyth, F E, Darcy, P K, Tainton, K, Neeson, P, Ritchie, D S, Hönemann, D

    Published in Gene therapy (01-05-2010)
    “…We have evaluated the carbohydrate antigen Lewis Y (Le Y ) as a potential target for T-cell immunotherapy of hematological neoplasias. Analysis of 81 primary…”
    Get full text
    Journal Article
  2. 2

    Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype by Neeson, P, Shin, A, Tainton, K M, Guru, P, Prince, H M, Harrison, S J, Peinert, S, Smyth, M J, Trapani, J A, Kershaw, M H, Darcy, P K, Ritchie, D S

    Published in Gene therapy (01-09-2010)
    “…The anti-tumor efficacy of adoptively transferred T cells requires their in vivo persistence and memory polarization. It is unknown if human chimeric antigen…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice by Westwood, J A, Murray, W K, Trivett, M, Shin, A, Neeson, P, MacGregor, D P, Haynes, N M, Trapani, J A, Mayura-Guru, P, Fox, S, Peinert, S, Honemann, D, Prince, H M, Ritchie, D, Scott, A M, Smyth, F E, Smyth, M J, Darcy, P K, Kershaw, M H

    Published in Gene therapy (01-07-2008)
    “…There is considerable concern regarding the transforming potential of retroviral vectors currently used for gene therapy, with evidence that retroviral…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Genetic modification of haematopoietic cells for combined resistance to podophyllotoxins, other agents covered by MDR1-mediated efflux activity and nitrosoureas by Baum, C, Peinert, S, Carpinteiro, A, Eckert, H G, Fairbairn, L J

    Published in Bone marrow transplantation (Basingstoke) (01-05-2000)
    “…Genetic transfer and expression of drug-resistance functions into haematopoietic stem and progenitor cells is a promising means to overcome both the acute and…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Ex vivo culture of chimeric antigen receptor T cells generates functional [CD8.sup.+] T cells with effector and central memory-like phenotype by Neeson, P, Shin, A, Tainton, K.M, Guru, P, Prince, H.M, Harrison, S.J, Peinert, S, Smyth, M.J, Trapani, J.A, Kershaw, M.H, Darcy, P.K, Ritchie, D.S

    Published in Gene therapy (01-09-2010)
    “…The anti-tumor efficacy of adoptively transferred T cells requires their in vivo persistence and memory polarization. It is unknown if human chimeric antigen…”
    Get full text
    Journal Article
  9. 9

    Ex vivo culture of chimeric antigen receptor T cells generates functional CD8 super(+) T cells with effector and central memory-like phenotype by Neeson, P, Shin, A, Tainton, K M, Guru, P, Prince, H M, Harrison, S J, Peinert, S, Smyth, M J, Trapani, J A, Kershaw, M H, Darcy, P K, Ritchie, D S

    Published in Gene therapy (01-09-2010)
    “…The anti-tumor efficacy of adoptively transferred T cells requires their in vivo persistence and memory polarization. It is unknown if human chimeric antigen…”
    Get full text
    Journal Article
  10. 10

    BECAM: A salvage protocol with bevacizumab, capecitabin, and mitomycin C for patients with refractory metastatic colorectal cancer (CRC) or gastric cancer (GC) by Peinert, S., Arnold, D., Siewczynski, R., Kegel, T., Heider, C., Nietsch, H., Schmoll, H.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 13554 Background: Bevacizumab (Bev), a monoclonal antibody targeted against VEGF, has shown to improve efficacy in CRC when combined with…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14